Top news of 2025: Drugmakers invest in US capacities, agree to lower Medicaid prices; Pfizer buys obesity-focused biotech Metsera

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Duratuss G

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 15 USDMF, 8 CEP/COS, 3 JDMF, 5 EU WC, 6 KDMF, 19 NDC API, 31 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

26 Drugs in Development

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

242 FDF Dossiers, 51 FDA Orange Book, 50 Europe, 68 Canada, 23 South Africa, 50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML, TABLET, EXTENDED RELEASE;ORAL - 1.2GM, TABLET, EXTENDED RELEASE;ORAL - 600MG, TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG, TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG, TABLET, EXTENDED RELEASE;ORAL - 30MG;600MG, TABLET, EXTENDED RELEASE;ORAL - 60MG;1.2GM, SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Minakem, 1 Evonik, 11 Rochem International Inc, 24 SPI Pharma, 24 DKSH, 2 Pharm-RX Chemical, 13 Boai NKY Pharmaceuticals Ltd, 10 Gangwal Healthcare, 17 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 12 Kirsch Pharma, 4 ACG Worldwide, 19 Actylis, 4 Aeon Procare, 2 Alcedo Pharmachem, 10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 1 Avesta Pharma, 40 BASF, 2 Bioplus Life Sciences, 3 CD Formulation, 4 Clariant, 16 Corel Pharma Chem, 6 DFE Pharma, 3 Esteem Industries, 4 Finar, 16 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 5 Ideal Cures, 5 Ingredion Pharma Solutions, 22 Kerry, 4 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 23 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 5 Novo Excipients, 4 Pharmatrans-Sanaq, 10 Pluviaendo, 4 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 56 Roquette, 19 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 3 Shijiazhuang Huaxu Pharmaceutical, 11 Sigachi Industries, 4 Silverline Chemicals, 1 Symrise, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 3 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

113 Fillers, Diluents & Binders, 87 Thickeners and Stabilizers, 67 Solubilizers, 60 Coating Systems & Additives, 50 Parenteral, 50 Taste Masking, 50 Direct Compression, 50 Topical, 47 Disintegrants & Superdisintegrants, 40 Controlled & Modified Release, 40 Granulation, 35 Film Formers & Plasticizers, 28 Lubricants & Glidants, 26 Chewable & Orodispersible Aids, 22 Emulsifying Agents, 21 Rheology Modifiers, 16 Co-Processed Excipients, 15 Surfactant & Foaming Agents, 13 API Stability Enhancers, 9 Empty Capsules, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

DIGITAL CONTENT

50 News #PharmaBuzz

50 News #PharmaBuzz

MARKET PLACE

32 APIs

32 APIs

PATENTS & EXCLUSIVITIES

3 US Patents

3 US Patents

REF. STANDARDS & IMPURITIES

1 EDQM, 2 JP, 15 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
30/12/2025	Granules India Limited	India	Hwail Pharmaceutical Co., Ltd.	20210309-211-J-857(3)	Guaifenesin	2021-11-30	Granules India Limited	India	15A/1, IDA, Phase-III, Jeedimetla, Quthbullapur Mandal, Malkajgiri Dist – 500055, Telangana State, India
06/01/2026	Synthokem Labs	India	Aging Life Science Co., Ltd.	20251215-211-J-2076	Guaifenesin	2025-12-15	Synthokem Labs Private Ltd.	India	Unit-Ⅱ Plot No. 222 to 224 & 235 to 237 Phase-Ⅱ, IDA, Pashamylaram Patancheru Mandal, Sangareddy District, Telangana State, India.

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Duratuss G

Duratuss G

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers

15 USDMF

8 CEP/COS

3 JDMF

5 EU WC

6 KDMF

19 NDC API

31 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

26 Drugs in Development

FINISHED DOSAGE FORMULATIONS

242 FDF Dossiers

51 FDA Orange Book

50 Europe

68 Canada

23 South Africa

50 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML

TABLET, EXTENDED RELEASE;ORAL - 1.2GM

TABLET, EXTENDED RELEASE;ORAL - 600MG

TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG

TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG

TABLET, EXTENDED RELEASE;ORAL - 30MG;600MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;1.2GM

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Minakem

1 Evonik

11 Rochem International Inc

24 SPI Pharma

24 DKSH

2 Pharm-RX Chemical

13 Boai NKY Pharmaceuticals Ltd

10 Gangwal Healthcare

17 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

12 Kirsch Pharma

4 ACG Worldwide

19 Actylis

4 Aeon Procare

2 Alcedo Pharmachem

10 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

1 Avesta Pharma

40 BASF

2 Bioplus Life Sciences

3 CD Formulation

4 Clariant

16 Corel Pharma Chem

6 DFE Pharma

3 Esteem Industries

4 Finar

16 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

5 Ideal Cures

5 Ingredion Pharma Solutions

22 Kerry

4 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

5 Lubrizol Life Science Health

23 Microlex e.U

3 Nanjing Bold Chemical

2 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

5 Novo Excipients

4 Pharmatrans-Sanaq

10 Pluviaendo

4 Prachin Chemical